SCHEMBL5200823

SCHEMBL5200823

CC(C)(C)N1C(=O)C(NCC(F)(F)F)=C(c2ccccc2)S1(=O)=O.CC(C)(C)N1C(=O)C(NCC(O)CO)=C(c2ccccc2)S1(=O)=O.CC(C)(C)N1C(=O)C(NCCC#N)=C(c2ccccc2)S1(O)O.CC(C)(C)N1C(=O)C(NCCc2ccc(OC(F)(F)F)cc2)=C(c2ccccc2)S1(=O)=O.COc1ccc(CCNC2=C(c3ccccc3)S(=O)(=O)N(C(C)C)C2=O)cc1Cl.COc1ccc(CCNC2=C(c3ccccc3)S(=O)(=O)N(C(C)C)C2=O)cc1OC

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
GAA P10253 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PTGER1 P34995 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5331966 0.90 SMN1; SMN2 (0.35) ALDH1A1MAPTGAAMAPK1SMN1; SMN2
SCHEMBL1997180 0.72 SMN1; SMN2 (0.49) ALDH1A1MAPTGAAMAPK1SMN1; SMN2
SCHEMBL1998299 0.70 NR1H2 (0.44) ALDH1A1MAPT
SCHEMBL2003485 0.70 SMN1; SMN2 (0.54) ALDH1A1MAPTGAAMAPK1SMN1; SMN2
SCHEMBL1999789 0.65 NR1H2 (0.49) SMN1; SMN2
SCHEMBL1997881 0.63 TOP2A (0.42) ALDH1A1MAPTGAAMAPK1SMN1; SMN2
SCHEMBL2001465 0.62 ABCB1 (0.39) ALDH1A1MAPT
SCHEMBL2000315 0.62 NR1H2 (0.53)
SCHEMBL2001466 0.62 NR1H2 (0.45) ALDH1A1MAPT
SCHEMBL5308618 0.62 NR1H2 (0.36) ALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838687-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP claimed
WO-2006073366-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO claimed